Abstract

UCSF and UT Southwestern researchers have shown that direct reprogramming of cardiac fibroblasts into cardiomyocyte-like cells is feasible in vivo and could promote the recovery of cardiac function after myocardial infarction. LoneStar Heart has exclusively licensed the UT Southwestern technology.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call